Cannabis News
The Death of a Marijuana Worker
While most occupations avoid headline-grabbing gore, innocuous vocations still inflict insidious damage through airborne threats eroding lung function over years. The phantom menace of ambient workplace toxicity carries an untold toll – including risk of sudden asphyxiation when cumulative exposures trigger acute attacks.
Consider “baker’s lung” – an asthma-like inflammation that develops from inhaling airborne grain and flour particles. This chronic disease forced many passionate artisans to abandon their craft over suffocating distress.
Hair stylists face analogous respiratory risks from potent chemical fumes permeating salons daily, as do factory workers breathing manufacturing particulates. The hazardous substances differ but the outcome feels identical – airways constricting and careers crushed through no direct misstep of their own.
In most cases, safety guidelines and equipment lag behind scientific understanding of emerging environmental illnesses. Thus, regulatory cracks allow once benign-seeming jobs to turn tragic before precautions adapt. Attributing blame becomes complex when unintended aspects of simple work carry unintended negative health consequences over time.
This ongoing issue underlies the first reported death of a cannabis industry worker recently – a 27 year old woman in Massachusetts suffered fatal asthma attack allegedly induced by workplace irritant exposure after previously managing her condition fine.
While the budding cannabis production sector hardly evokes hazards on par with industrial meatpacking or mine drilling, it still breeds its own singular risks, as regulators race to understand. When prohibition gives way to mass cultivation, new variables emerge.
So today, we will explore this tragic accident within its broader context – well-meaning workers undone by latent threats in substances at first sniff seemingly harmless enough. But when health hangs in the balance of unknowns, caution takes on grave urgency.
Let us honor this woman’s memory then by scrutinizing the growing pains of an industry rushing to meet demand. If preventing the next victim means pausing enthusiasm for patient access, the tradeoff seems clear. For in the end, no reefer revolution succeeds on backs broken laboring in shadows.
First, do no harm.
This young woman’s tragic death represents a watershed moment for the nascent cannabis industry to mature its ethical priorities around worker safety. While an individual loss first and foremost, her unnecessary passing will undoubtedly save future lives through forcing regulatory awareness and accountability.
Inspectors noted the facility had not established respiratory protections for staff handling volumes of agitated cannabis dust hazardous to compromised systems. But in fairness, few viability guidelines existed around large-scale commercial cultivation when early operators raced to capitalize on legalization. But playing the devil’s advocate – it might be kind of obvious to ensure worker’s protections in an enclosed space with plant matter floating in the air.
The vast underground cannabis production knowledge understandably emphasized concealment and profitability over governance with workplace hazards an afterthought. Now that full legitimacy and scalability replaces shadowy improvisation, codifying revised best practices falls on regulators.
This expectant shift from illicit business to regulated corporate enterprise was bound to endure painful lessons given the pace of social change outpacing bureaucratic preparations.
But through those legislative growing pains, let us at least extract meaning from suffering to bless broader communities. Industry crucibles should purify, not corrupt, our integrity.
With cannabis governance still evolving conceptually, what better opportunity to embed safety-first regulatory models before harmful norms cement? Other sectors have learned similar lessons too late after normalizing harm. Cannabis need not repeat history’s errors.
This tragedy powerfully demonstrates why writing compassion into policy protects all. And if legacy operators wish to speak convincingly about ethical industry standards, addressing worker welfare makes the perfect starting point.
May this loss provide the urgent impetus to build cannabis production regulations correctly the first time as exemplary frameworks prioritizing people over profits. That outcome would make this woman’s unwarranted death not in vain, but an indispensable catalyst bettering society.
While the cannabis worker’s death has raised concerns around respiratory risks from mass cultivation, her underlying asthma represents an often minimized health crisis facing over 25 million Americans today. Asthma proves one of the nation’s most common, underestimated and deadly chronic conditions.
Over 10% of American adults suffer asthma currently, with rates highest among minorities and women. Triggers range from allergy irritants to pollution to respiratory infections. But outcomes can quickly turn fatal without proper prevention and treatment.
In fact, a shocking 39% of asthmatic adults reported experiencing attacks recently, signaling vast unmet care needs. And after decades of declines, death tolls are actually rising again, taking ten lives daily.
Behind those abstract figures lie needless everyday suffering and lost livelihoods as asthma constricts once active lives. Simple tasks turn laborious amidst terrifying bouts of breathlessness. And the condition worsens over time without tight symptom control.
Too often the social stigma around asthma invites blame, minimizing its trauma as an imagined ailment instead of recognizing its lethal reality. Yet epidemiology shows no group immune from onset as inflammation disables airways without warning.
Even physically fit individuals find themselves unexpectedly hospitalized, bedridden for weeks after sudden attacks. If the pandemic taught anything, breath stands among our most precious assumed attributes until compromised.
And marginalized groups shoulder the harshest asthma impacts, facing eroded quality of life and early death – especially Black women. These unjust outcomes demand policy attention on par with splashier diseases like COVID but of course, the treatment options aren’t always pharmaceutical – there are practical methods of working with the lungs and strengthening it. In fact, asthmatics should totally do breathwork!
Yet care infrastructure remains sorely lacking for proper asthma management beyond quick-fix inhalers and emergency interventions. Patients lack sustained access to preventative anti-inflammatory regimens, home air purifiers, allergen avoidance education and mental healthcare.
In this woman’s case, the risks tragically proved insurmountable given workplace irritant exposures. But better safety regulations alongside elevated clinical treatment could have prevented such catastrophe.
Ultimately her death illuminates twin priorities – destigmatizing asthma as easily managed while strengthening societal infrastructure supporting patients long-term. Because the occasional frightening attacks hide in plain sight chronic day-to-day ordeals for millions that our healthcare system continues neglecting at their peril, sometimes fatally.
This young woman’s sudden passing at 27 over an invisible workplace threat sparks calls to balance cannabis reform zeal with cautions of unintended consequences from breakneck policy change. But ultimately all sides share the goal of preventing such needless loss.
And from crisis wisdom crystallizes. Asthma safety protocols will now enter cultivation facility regulations to protect other vulnerable industry laborers. Her legacy thus uplifts colleagues through institutional evolution she helped initiate.
The sticky truth remains that prohibition’s end creates new dialogue around health tradeoffs from increased access and production. But reasonable guardrails arise through compassionate debate, not scare tactics demonizing the plant itself.
With cannabis, as all medicines, responsible frameworks honoring human dignity over profit must prevail. And each tragedy underlines the work remaining to place community wellbeing first amidst commercialized healthcare.
Yet as we walk this complex path together, broader perspective seems vital too – that life’s impermanence claims all fates regardless of circumstance. However graciously lived, no mortal bypasses death in the end.
So this incident should remind us as bystanders to love boldly, forgive freely, speak kindly, waste no days in grievance. For in between first breath and last, meaning weaves through bonds nurturing each other against the endless entropy.
Few depart expecting their curtain call so soon or suddenly. But in that obscurity lies wisdom to consciously cherish each transient now beyond assumed tomorrows. The thriving cannabis movement must model this mindfulness.
Honor this woman then by embedding vigilance into your protocols and presence into your days. Uplift colleagues through purposeful work culture. Allow loss to reveal life’s urgency. The rest flows through awakened hearts connected to transient blessings blooming all around if we pause to perceive them.
CANNABIS DUST IN THE AIR, READ ON…
Cannabis News
Latest Trump Weed Rumor – Trump Will Federally Deschedule and Decriminalize Cannabis, but Not Legalize It
In a recent interview, former New Jersey Governor Chris Christie made headlines by asserting that President-elect Donald Trump will pursue significant reforms in federal policies regarding marijuana and cryptocurrency. As the nation grapples with evolving attitudes toward cannabis and the burgeoning digital currency market, Christie’s predictions have ignited discussions about the potential implications of such changes on both industries. This article delves into Christie’s insights, the current state of marijuana and cryptocurrency regulations, and the broader implications of these anticipated reforms.
The Current Landscape of Marijuana Legislation
Federal vs. State Laws
Marijuana remains classified as a Schedule I substance under the Controlled Substances Act (CSA), which places it in the same category as heroin and LSD. This classification has created a complex legal landscape where states have moved to legalize cannabis for medical and recreational use, while federal law continues to impose strict prohibitions. As of now, over 30 states have legalized marijuana in some form, leading to a burgeoning industry that generates billions in revenue.
Challenges Faced by the Cannabis Industry
Despite its legality in many states, the cannabis industry faces significant hurdles due to federal restrictions. These challenges include:
-
Banking Access: Many banks are hesitant to work with cannabis businesses due to fear of federal repercussions, forcing these businesses to operate largely in cash.
-
Taxation Issues: The IRS enforces Section 280E of the tax code, which prohibits businesses engaged in illegal activities from deducting normal business expenses, leading to disproportionately high tax burdens for cannabis companies.
-
Interstate Commerce: The lack of federal legalization prevents cannabis businesses from operating across state lines, limiting their growth potential.
Chris Christie’s Perspective on Marijuana Reform
Christie, a former presidential candidate known for his tough stance on drugs during his tenure as governor, has evolved his views on marijuana over the years. In his recent statements, he emphasized that Trump is likely to pursue descheduling cannabis, which would remove it from the Schedule I classification. This move would not only provide clarity for businesses operating in legal markets but also open avenues for banking and investment.
Christie highlighted that descheduling would allow for a more regulated market where safety standards could be established, thus protecting consumers. He believes that this approach aligns with a growing consensus among Americans who support legalization and recognize the potential benefits of cannabis use for both medical and recreational purposes.
The Future of Cryptocurrency Regulation = The Rise of Cryptocurrencies
Cryptocurrencies have surged in popularity over the past decade, with Bitcoin leading the charge as the first decentralized digital currency. The market has expanded to include thousands of alternative coins (altcoins), each with unique features and use cases. As cryptocurrencies gain traction among investors and consumers alike, regulatory scrutiny has intensified.
Current Regulatory Challenges
The cryptocurrency market faces several regulatory challenges that hinder its growth and adoption:
-
Lack of Clarity: Regulatory frameworks vary significantly across states and countries, creating confusion for investors and businesses.
-
Fraud and Scams: The rapid growth of cryptocurrencies has led to an increase in fraudulent schemes targeting unsuspecting investors.
-
Consumer Protection: Without clear regulations, consumers are often left vulnerable to risks associated with volatile markets.
Christie’s Vision for Crypto Regulation
Christie believes that under Trump’s leadership, there will be an effort to find a “sweet spot” for cryptocurrency regulation balancing innovation with consumer protection. He argues that overly stringent regulations could stifle growth in this emerging sector while too little oversight could expose consumers to significant risks.
In his view, a balanced regulatory framework would include:
1. Clear Definitions: Establishing clear definitions for different types of cryptocurrencies and tokens to differentiate between securities and utility tokens.
2. Consumer Protections: Implementing measures to protect investors from fraud while promoting transparency within the market.
3. Encouraging Innovation: Creating an environment conducive to innovation by allowing startups to thrive without excessive regulatory burdens.
Christie’s insights reflect a growing recognition among policymakers that cryptocurrencies are here to stay and that appropriate regulations are necessary to foster growth while safeguarding consumers.
Implications of Proposed Reforms
Economic Impact
The potential reforms proposed by Christie could have far-reaching economic implications:
-
Job Creation: Legalizing marijuana at the federal level could lead to significant job creation within the cannabis industry—from cultivation and production to retail sales.
-
Investment Opportunities: Descheduling cannabis would open up investment opportunities for institutional investors who have been hesitant due to federal restrictions.
-
Boosting Local Economies: Legal cannabis markets have proven beneficial for local economies through increased tax revenues and job creation.
Similarly, clear regulations around cryptocurrencies could stimulate investment in blockchain technology and related industries, fostering innovation and economic growth.
Social Justice Considerations
Both marijuana legalization and sensible cryptocurrency regulations have social justice implications:
-
Addressing Past Injustices: Legalizing marijuana could help rectify past injustices related to drug enforcement policies that disproportionately affected marginalized communities.
-
Financial Inclusion: Cryptocurrencies offer opportunities for financial inclusion for those underserved by traditional banking systems, particularly in low-income communities.
Political Landscape
The political landscape surrounding these issues is complex. While there is bipartisan support for marijuana reform among certain lawmakers, challenges remain in overcoming entrenched opposition. Similarly, cryptocurrency regulation has garnered attention from both sides of the aisle but requires collaboration to establish effective frameworks.
Conclusion
Chris Christie’s predictions about President-elect Donald Trump’s approach to federal marijuana descheduling and cryptocurrency regulation suggest a potential shift in U.S. policy that could significantly reshape both industries. As public opinion evolves on these issues, lawmakers have an opportunity to enact meaningful reforms that promote economic growth while ensuring consumer protection. The anticipated changes could foster a more robust cannabis industry that contributes positively to the economy and addresses social justice concerns, while clear regulatory frameworks for cryptocurrencies could encourage innovation and protect consumers in the digital economy. Stakeholders in both sectors are closely watching these developments, eager to see how potential reforms might impact their futures. While the realization of Christie’s predictions remains uncertain, it’s clear that the conversation around marijuana and cryptocurrency regulation is ongoing and far from settled.
TRUMP 2.0 ON CANNABIS REFORM, READ ON…
TRUMP 2.0 ON FEDERAL CANNABIS REFORM – WHAT DO WE KNOW?
“How Long Does One Puff of Weed Stay in Your System?”… This topic can be difficult to answer since it is dependent on elements such as the size of the hit and what constitutes a “one hit.” If you take a large bong pull then cough, it might linger in your system for 5-7 days. A moderate dose from a joint can last 3-5 days, whereas a few hits from a vaporizer may last 1-3 days.
The length of time that marijuana stays in the body varies based on a number of factors, including metabolism, THC levels, frequency of use, and hydration.
Delta-9-tetrahydrocannabinol, or THC, is the primary psychoactive component of cannabis. THC and its metabolites, which remain in your body long after the effects have subsided, are detected by drug tests.
Since these metabolites are fat-soluble, they cling to bodily fat molecules. They could thus take a while to fully pass through your system, particularly if your body fat percentage is higher.
THC is absorbed by tissues and organs (including the brain, heart, and fat) and converted by the liver into chemicals such as 11-hydroxy-THC and carboxy-THC. Cannabis is eliminated in feces at a rate of around 65%, while urine accounts for 20%. The leftover amount might be kept within the body.
THC deposited in bodily tissues ultimately re-enters the circulation and is processed by the liver. For frequent users, THC accumulates in fatty tissues quicker than it can be removed, thus it may be detectable in drug tests for days or weeks following consumption.
The detection time varies according to the amount and frequency of cannabis usage. Higher dosages and regular usage result in longer detection times.
The type of drug test also affects detection windows. Blood and saliva tests typically detect cannabis metabolites for shorter periods, while urine and hair samples can reveal use for weeks or even months. In some cases, hair tests have detected cannabis use over 90 days after consumption.
Detection Windows for Various Cannabis Drug Tests
Urine Tests
Among all drug tests, urine testing is the most commonly used method for screening for drug use in an individual.
Detection times vary, but a 2017 review suggests the following windows for cannabis in urine after last use:
– Single-use (e.g., one joint): up to 3 days
– Moderate use (around 4 times a week): 5–7 days
– Chronic use (daily): 10–15 days
– Chronic heavy use (multiple times daily): over 30 days
Blood Tests
Blood tests generally detect recent cannabis use, typically within 2–12 hours after consumption. However, in cases of heavy use, cannabis has been detected up to 30 days later. Chronic heavy use can extend the detection period in the bloodstream.
Saliva Tests
THC can enter saliva through secondhand cannabis smoke, but THC metabolites are only present if you’ve personally smoked or ingested cannabis.
Saliva testing has a short detection window and can sometimes identify cannabis use on the same day. A 2020 review found that THC was detectable in the saliva of frequent users for up to 72 hours after use, and it may remain in saliva longer than in blood following recent use.
In areas where cannabis is illegal, saliva testing is often used for roadside screenings.
Hair Tests
Hair follicle tests can detect cannabis use for up to 90 days. After use, cannabinoids reach the hair follicles through small blood vessels and from sebum and sweat surrounding the hair.
Hair grows at approximately 0.5 inches per month, so a 1.5-inch segment of hair close to the scalp can reveal cannabis use over the past three months.
Factors Affecting THC and Metabolite Retention
The length of time THC and its metabolites stay in your system depends on various factors. Some, like body mass index (BMI) and metabolic rate, relate to individual body processing, not the drug itself.
Other factors are specific to cannabis use, including:
– Dosage: How much you consume
– Frequency: How often you use cannabis
– Method of consumption: Smoking, dabbing, edibles, or sublingual
– THC potency: Higher potency can extend detection time
Higher doses and more frequent use generally extend THC retention. Cannabis consumed orally may remain in the system slightly longer than smoked cannabis, and stronger cannabis strains, higher in THC, may also stay detectable for a longer period.
How Quickly Do the Effects of Cannabis Set In?
When smoking cannabis, effects appear almost immediately, while ingested cannabis may take 1–3 hours to peak.
The psychoactive component THC produces a “high” with common effects such as:
– Altered senses, including perception of time
– Mood changes
– Difficulty with thinking and problem-solving
– Impaired memory
Other short-term effects can include:
– Anxiety and confusion
– Decreased coordination
– Dry mouth and eyes
– Nausea or lightheadedness
– Trouble focusing
– Increased appetite
– Rapid heart rate
– Restlessness and sleepiness
In rare cases, high doses may lead to hallucinations, delusions, or acute psychosis.
Regular cannabis use may have additional mental and physical effects. While research is ongoing, cannabis use may increase the risk of:
– Cognitive issues like memory loss
– Cardiovascular problems including heart disease and stroke
– Respiratory illnesses such as bronchitis or lung infections
– Mood disorders like depression and anxiety
Cannabis use during pregnancy can negatively impact fetal growth and development.
Duration of Effects
Short-term effects generally taper off within 1–3 hours, but for chronic users, some long-term effects may last days, weeks, or even months. Certain effects may even be permanent.
Bottom Line
The amount of time that cannabis remains in your system following a single use varies greatly depending on individual characteristics such as body fat, metabolism, frequency of use, and mode of intake. Frequent users may maintain traces of THC for weeks, whereas infrequent users may test positive for as little as a few days. Hair tests can disclose usage for up to 90 days, while blood and saliva tests identify more recent use. Urine tests are the most popular and have varying detection durations. The duration that THC and its metabolites are detectable will ultimately depend on a number of factors, including dose, strength, and individual body chemistry.
PEE IN A CUP COMING UP, READ ON..
Latest Trump Weed Rumor – Trump Will Federally Deschedule and Decriminalize Cannabis, but Not Legalize It
Webinar Replay: Post-Election Cannabis Wrap – Smoke ’em if You’ve Got ’em
I Had Just One Puff
Marijuana firms Eaze, Green Dragon find new life after $10 million capital infusion
Get some rest on Modified Grapes—November’s Leafly HighLight
Is Kratom Addictive? Understanding Dependence, Risks, and Safe Usage
New Rule, December 5: Oregon Cannabis Retailers, Processors and Labor Peace Agreements
The CBD Dog Treat Guide
Trippin’ Golf Balls – Can Magic Mushrooms Help Your Golf Game?
Australian Broadcasting Corp Alleges Military Veterans Have Been Targeted By Medicinal Cannabis Companies Via Social Media & Offered Free “Product”
Distressed Cannabis Business Takeaways – Canna Law Blog™
United States: Alex Malyshev And Melinda Fellner Discuss The Intersection Of Tax And Cannabis In New Video Series – Part VI: Licensing (Video)
What you Need to Know
Drug Testing for Marijuana – The Joint Blog
NCIA Write About Their Equity Scholarship Program
It has been a wild news week – here’s how CBD and weed can help you relax
Cannabis, alcohol firm SNDL loses CA$372.4 million in 2022
A new April 20 cannabis contest includes a $40,000 purse
Your Go-To Source for Cannabis Logos and Designs
UArizona launches online cannabis compliance online course
-
Cannabis News2 years agoDistressed Cannabis Business Takeaways – Canna Law Blog™
-
One-Hit Wonders2 years agoUnited States: Alex Malyshev And Melinda Fellner Discuss The Intersection Of Tax And Cannabis In New Video Series – Part VI: Licensing (Video)
-
Cannabis 1012 years agoWhat you Need to Know
-
drug testing11 months agoDrug Testing for Marijuana – The Joint Blog
-
Education2 years agoNCIA Write About Their Equity Scholarship Program
-
Cannabis2 years agoIt has been a wild news week – here’s how CBD and weed can help you relax
-
Marijuana Business Daily2 years agoCannabis, alcohol firm SNDL loses CA$372.4 million in 2022
-
California2 years agoA new April 20 cannabis contest includes a $40,000 purse